Aldeyra Therapeutics, Inc. (ALDX)

1.59 +0.07 (+4.61%) USD  |  NASDAQ  |  May 01, 16:00
1.59 0.00 (0.00%) After-Hours: 20:00
More

Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.1074 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.508
Rhythm Pharmaceuticals, Inc. -0.7302
Pfizer Inc. -0.2898
AbbVie, Inc. 0.3918
Glaukos Corp. -0.341

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -6.462M
Total Expenses (Quarterly) 6.462M
Enterprise Value 41.18M
Earnings Yield -35.46%
Normalized Earnings Yield -35.45